Qualigen Therapeutics Inc (QLGN) — Cash Flow Reinvestment Rate

Latest as of September 2023: 4.81x

Qualigen Therapeutics Inc (QLGN) has a Cash Flow Reinvestment Rate of 4.81x as of September 2023, reinvesting $4.47 Million (capex $246.42K plus investments $4.23 Million) from operating cash flow of $929.74K. Check cash flow quality index of Qualigen Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

4.81x

(Capex + Investments) / Operating CF

Total Reinvested

$4.47 Million

Capex + Investments

Operating Cash Flow

$929.74K

USD

Capital Expenditures

$246.42K

USD

Qualigen Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Qualigen Therapeutics Inc across 1 annual periods. Explore Qualigen Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Qualigen Therapeutics Inc (2019–2019)

Year-by-year capital reinvestment analysis for Qualigen Therapeutics Inc. For live market cap and broader valuation context, see market value of Qualigen Therapeutics Inc.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2019	6.78x	$388.95K	$57.33K	$194.48K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow